Molineux G, Xu C, Hendry J, Testa N G
Cancer Chemother Pharmacol. 1986;18(1):11-6. doi: 10.1007/BF00253055.
Following repeated treatment of mice with cyclophosphamide (5 X 200 mg/kg) it was found that slight, but significant, residual marrow damage persisted for at least half the lifespan of the animals. This long-term damage occurred despite preferential sparing of those multi-potential haematopoietic cells (CFU-S) that had a high self-renewal capacity after each step of the multistep regimen and despite a smaller CFU-S kill after each successive dose. The damage was characterized by low mean numbers of CFU-S and stromal colony-forming cells (CFU-F) which were around 70% of control values. Examination of individual animals revealed that the majority had slightly subnormal numbers of CFU-S and CFU-F, with only a few suffering a more severe injury, including 8% of mice with clinical hypoplasia or myelodysplasia.
在用环磷酰胺(5×200mg/kg)反复治疗小鼠后,发现轻微但显著的残留骨髓损伤持续存在于动物至少一半的寿命期内。尽管在多步骤方案的每个步骤后,具有高自我更新能力的多能造血细胞(CFU-S)得到了优先保留,并且每次连续给药后CFU-S的杀伤作用较小,但仍发生了这种长期损伤。损伤的特征是CFU-S和基质集落形成细胞(CFU-F)的平均数量较低,约为对照值的70%。对个体动物的检查显示,大多数动物的CFU-S和CFU-F数量略低于正常水平,只有少数动物遭受更严重的损伤,包括8%的小鼠出现临床发育不全或骨髓发育异常。